Interchangeability Impacting Biosimilar Uptake

The panel discusses the impact of interchangeability and value of switching studies in biosimilar adoption.

Video content above is prompted by the following:

  • Has interchangeability impacted biosimilar adoption? If not, why?
    • What value do switching studies bring to interchangeable biosimilars?
      • Does this data matter more than the designation?
    • Do pharmacies and providers value interchangeability?
    • Have pharmacies begun acting upon interchangeability with automatic substitutions?
Related Videos
A panel of 5 experts on RSV
A panel of 5 experts on RSV
Related Content
CH LogoCenter for Biosimilars Logo